FDA recall D-0577-2020

Product

25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10

Reason for recall

Labeling: Incorrect or Missing Lot and/or expiration date.

Distribution

Nationwide within the United States including Puerto Rico.

Key facts

Status

Terminated

Initiation date

2019-11-27

Report date

2019-12-18

Termination date

2022-01-14

Voluntary/Mandated

Voluntary: Firm initiated

Location

New York, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0577-2020